HOLLIS EDEN PHARMACEUTICALS INC /DE/
10-Q, EX-27, 2000-11-13
PHARMACEUTICAL PREPARATIONS
Previous: HOLLIS EDEN PHARMACEUTICALS INC /DE/, 10-Q, 2000-11-13
Next: IMAGINON INC /DE/, SC 13D/A, 2000-11-13



<TABLE> <S> <C>

<PAGE>

<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM THE
COMPANY'S FORM 10-Q FOR THE NINE MONTH PERIOD ENDED SEPTEMBER 30, 2000 AND IS
QUALIFIED IN ITS ENTIRETY BY REFERENCE TO SUCH FINANCIAL STATEMENTS.
</LEGEND>

<S>                             <C>
<PERIOD-TYPE>                   9-MOS
<FISCAL-YEAR-END>                          DEC-31-2000
<PERIOD-START>                             JAN-01-2000
<PERIOD-END>                               SEP-30-2000
<CASH>                                          38,776
<SECURITIES>                                         0
<RECEIVABLES>                                        0
<ALLOWANCES>                                         0
<INVENTORY>                                          0
<CURRENT-ASSETS>                                38,946
<PP&E>                                             549
<DEPRECIATION>                                     176
<TOTAL-ASSETS>                                  39,700
<CURRENT-LIABILITIES>                            2,103
<BONDS>                                              0
                                0
                                          0
<COMMON>                                           114
<OTHER-SE>                                      37,483
<TOTAL-LIABILITY-AND-EQUITY>                    39,700
<SALES>                                              0
<TOTAL-REVENUES>                                     0
<CGS>                                                0
<TOTAL-COSTS>                                   23,173
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                   0
<INCOME-PRETAX>                               (21,193)
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                           (21,193)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                  (21,193)
<EPS-BASIC>                                     (1.89)
<EPS-DILUTED>                                   (1.89)


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission